This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Universiteit Gent. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Ine Lentacker: Innovator in Therapeutic Nanoparticles
Introduction
Ine Lentacker is a prominent inventor based in Ledeberg, Belgium. He has made significant contributions to the field of therapeutic nanoparticles, particularly in the optimized delivery of nucleic acids. His work is crucial for advancements in immunotherapy and vaccination strategies.
Latest Patents
Ine Lentacker holds a patent for "Therapeutic nanoparticles and methods of use thereof." This invention relates to a method and composition designed for optimized intracellular delivery of nucleic acids, specifically mRNA. The composition may also include a glycolipid antigen and combinations with checkpoint inhibitors. The method targets antigen-presenting cells, making it especially useful for immunotherapy and vaccination purposes. He has 1 patent to his name.
Career Highlights
Ine Lentacker is affiliated with Universiteit Gent, where he continues to push the boundaries of research in therapeutic applications. His innovative approach to nanoparticle technology has garnered attention in the scientific community.
Collaborations
Ine has collaborated with notable colleagues, including Rein Verbeke and Stefaan De Smedt. Their combined expertise enhances the research and development of new therapeutic strategies.
Conclusion
Ine Lentacker's work in therapeutic nanoparticles represents a significant advancement in the field of medicine. His innovative methods and compositions are paving the way for future breakthroughs in immunotherapy and vaccination.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile